Navigation Links
Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
Date:12/8/2012

New York, New York (PRWEB) December 08, 2012

As transvaginal mesh lawsuits continue to move forward in state and federal courts, a newly-published study has found that prolapse procedures that utilize vaginal mesh products rose significantly between 2005 and 2010, Bernstein Liebhard LLP reports. The study, published online November 19, 2012, in the American Journal of Obstetrics & Gynecology, drew on claims data to examine trends in vaginal mesh prolapse procedures (VMs), abdominal sacrocolpopexy (ASC), and minimally invasive sacrocolpopexy (MISC) from 2005 to 2010. Overall, 74.9% of the procedures performed during that time period were vaginal mesh surgeries, for an overall rate of 56.9 per 100,000 person-years.*

“The increase in the use of vaginal mesh products during the period covered by the study is consistent with the introduction to the market of various transvaginal mesh kits for the treatment of pelvic organ prolapse. In light of the recent regulatory advisories regarding transvaginal mesh devices, we do not believe this study reflects current trends,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The firm is currently evaluating potential lawsuits on behalf of women who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to vaginal mesh.

Transvaginal Mesh Lawsuits
In July 2011, the U.S. Food & Drug Administration (FDA) warned that there had been a five-fold increase in reports of serious complications associated with the use of transvaginal mesh. The FDA also modified its previous position on the frequency of such complications, stating in the alert that vaginal mesh injuries associated with POP repair were not rare.**

Since the FDA advisory, a growing number of women have filed transvaginal mesh lawsuits alleging they experienced serious, painful and life-changing injuries following implantation of these devices to treat pelvic organ prolapse and stress urinary incontinence. Multidistrict litigations involving a number of manufacturers have been established in U.S. District Court, Southern District of West Virginia, including In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“ MDL No. 2327”). Consolidated litigations involving Johnson & Johnson Ethicon vaginal mesh products and C.R. Bard devices are also pending in New Jersey Superior Court ( In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10).

Bernstein Liebhard LLP partner, Jeffrey Grand, is serving on the Plaintiffs’ Steering Committees in all of the above federal litigations. In addition, Mr. Grand is serving as Co-Liason Counsel in both of the New Jersey Superior Court proceedings.

Women who suffered complications following implantation of transvaginal mesh may be entitled to compensation for their medical bills, pain and suffering, and other injuries. Bernstein Liebhard LLP is offering free lawsuit evaluations to any woman injured by vaginal mesh devices. A wealth of information regarding the firm's involvement with the ongoing pelvic mesh litigation can be found at Bernstein Liebhard's website, or call 1-877-779-1414 today.

*ajog.org/article/S0002-9378%2812%2902063-7/abstract
**fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/transvaginal-mesh-lawsuit/vaginal-mesh-lawsuit/prweb10216662.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Expands Their Transvaginal Mesh Initiative Because Of The Potential Number Of Victims & They are Offering the Names of the Best Women Attorneys To Help
2. US Drug Watchdog Now Offers All Victims Of A Transvaginal Mesh, Sling, or Tape Failure The Names And Contacts Of The Best Possible National Caliber Lawyers Who Are Women
3. US Drug Watchdog Now Urges Transvaginal Mesh, Tape Or Sling Failure Victims To Call Them For The Names Of The Best Possible Attorneys-Who Are All Also Women-Get Help Now
4. US Drug Watchdog Now Fears the Numbers of Transvaginal Mesh Product Failure Victims Will Grow and They Offer Victims the Names of the Best Lawyers-Who Will All Be Women
5. Johnson & Johnson Violated FDA Order to Halt Sales of Transvaginal Mesh
6. US Drug Watchdog Launches Now Calls Transvaginal Mesh A Disaster For 100,000's of US Women Recipients And Offers The Names and Contacts Of The Best Women Attorneys
7. Wright & Schulte File Skechers Lawsuit on Behalf of Ohio Woman Who Fell, Suffered Broken Wrist Allegedly Due to Use of Skechers Shape-Ups
8. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
9. New Lawsuit alleges Actos caused Bladder Cancer
10. New Lawsuit on Accutane Crohn’s Disease: Severe Adverse Events
11. New Lawsuit on Propecia: Severe Adverse Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: